Tag: Regeneron Pharmaceuticals

Federal, Policy

Regeneron signs a $450 million contract with the U.S. government for its coronavirus therapy

July 7, 2020


Regeneron Pharmaceuticals said on Tuesday the U.S. government signed a $450 million contract with the drugmaker to make and supply its potential double-antibody cocktail for Covid-19. The cocktail, REGN-COV2, is in separate clinical trials assessing its effectiveness in preventing and […]